Cargando…

Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?

SIMPLE SUMMARY: In the last twenty years, minimally invasive surgery (MIS) has radically changed the surgical landscape. In the field of thoracic surgery, approaches such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS) have become the new standards fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Berzenji, Lawek, Wen, Wen, Verleden, Stijn, Claes, Erik, Yogeswaran, Suresh Krishan, Lauwers, Patrick, Van Schil, Paul, Hendriks, Jeroen M. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487098/
https://www.ncbi.nlm.nih.gov/pubmed/37686557
http://dx.doi.org/10.3390/cancers15174281
_version_ 1785103157539373056
author Berzenji, Lawek
Wen, Wen
Verleden, Stijn
Claes, Erik
Yogeswaran, Suresh Krishan
Lauwers, Patrick
Van Schil, Paul
Hendriks, Jeroen M. H.
author_facet Berzenji, Lawek
Wen, Wen
Verleden, Stijn
Claes, Erik
Yogeswaran, Suresh Krishan
Lauwers, Patrick
Van Schil, Paul
Hendriks, Jeroen M. H.
author_sort Berzenji, Lawek
collection PubMed
description SIMPLE SUMMARY: In the last twenty years, minimally invasive surgery (MIS) has radically changed the surgical landscape. In the field of thoracic surgery, approaches such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS) have become the new standards for the majority of procedures performed, especially for early-stage lung cancer. Despite these developments, there is still a lack of concrete data regarding treatment outcomes of these minimally invasive approaches compared to the conventional open surgery. In the future, the number of minimally invasive procedures will likely keep increasing as more lung cancer nodules are detected at early stages due to lung cancer screening initiatives. Therefore, data on short- and long-term outcomes of VATS and RATS in early-stage lung cancer is needed. ABSTRACT: In the last two decades, robotic-assisted thoracoscopic surgery (RATS) has gained popularity as a minimally invasive surgical (MIS) alternative to multi- and uniportal video-assisted thoracoscopic surgery (VATS). With this approach, the surgeon obviates the known drawbacks of conventional MIS, such as the reduced in-depth perception, hand-eye coordination, and freedom of motion of the instruments. Previous studies have shown that a robotic approach for operable lung cancer has treatment outcomes comparable to other MIS techniques such as multi-and uniportal VATS, but with less blood loss, a lower conversion rate to open surgery, better lymph node dissection rates, and improved ergonomics for the surgeon. The thoracic surgeon of the future is expected to perform more complex procedures. More patients will enter a multimodal treatment scheme making surgery more difficult due to severe inflammation. Furthermore, due to lung cancer screening programs, the number of patients presenting with operable smaller lung nodules in the periphery of the lung will increase. This, combined with the fact that segmentectomy is becoming an increasingly popular treatment for small peripheral lung lesions, indicates that the future thoracic surgeons need to have profound knowledge of segmental resections. New imaging techniques will help them to locate these lesions and to achieve a complete oncologic resection. Current robotic techniques exist to help the thoracic surgeon overcome these challenges. In this review, an update of the latest MIS approaches and nodule detection techniques will be given.
format Online
Article
Text
id pubmed-10487098
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104870982023-09-09 Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand? Berzenji, Lawek Wen, Wen Verleden, Stijn Claes, Erik Yogeswaran, Suresh Krishan Lauwers, Patrick Van Schil, Paul Hendriks, Jeroen M. H. Cancers (Basel) Review SIMPLE SUMMARY: In the last twenty years, minimally invasive surgery (MIS) has radically changed the surgical landscape. In the field of thoracic surgery, approaches such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS) have become the new standards for the majority of procedures performed, especially for early-stage lung cancer. Despite these developments, there is still a lack of concrete data regarding treatment outcomes of these minimally invasive approaches compared to the conventional open surgery. In the future, the number of minimally invasive procedures will likely keep increasing as more lung cancer nodules are detected at early stages due to lung cancer screening initiatives. Therefore, data on short- and long-term outcomes of VATS and RATS in early-stage lung cancer is needed. ABSTRACT: In the last two decades, robotic-assisted thoracoscopic surgery (RATS) has gained popularity as a minimally invasive surgical (MIS) alternative to multi- and uniportal video-assisted thoracoscopic surgery (VATS). With this approach, the surgeon obviates the known drawbacks of conventional MIS, such as the reduced in-depth perception, hand-eye coordination, and freedom of motion of the instruments. Previous studies have shown that a robotic approach for operable lung cancer has treatment outcomes comparable to other MIS techniques such as multi-and uniportal VATS, but with less blood loss, a lower conversion rate to open surgery, better lymph node dissection rates, and improved ergonomics for the surgeon. The thoracic surgeon of the future is expected to perform more complex procedures. More patients will enter a multimodal treatment scheme making surgery more difficult due to severe inflammation. Furthermore, due to lung cancer screening programs, the number of patients presenting with operable smaller lung nodules in the periphery of the lung will increase. This, combined with the fact that segmentectomy is becoming an increasingly popular treatment for small peripheral lung lesions, indicates that the future thoracic surgeons need to have profound knowledge of segmental resections. New imaging techniques will help them to locate these lesions and to achieve a complete oncologic resection. Current robotic techniques exist to help the thoracic surgeon overcome these challenges. In this review, an update of the latest MIS approaches and nodule detection techniques will be given. MDPI 2023-08-26 /pmc/articles/PMC10487098/ /pubmed/37686557 http://dx.doi.org/10.3390/cancers15174281 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Berzenji, Lawek
Wen, Wen
Verleden, Stijn
Claes, Erik
Yogeswaran, Suresh Krishan
Lauwers, Patrick
Van Schil, Paul
Hendriks, Jeroen M. H.
Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
title Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
title_full Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
title_fullStr Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
title_full_unstemmed Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
title_short Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
title_sort minimally invasive surgery in non-small cell lung cancer: where do we stand?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487098/
https://www.ncbi.nlm.nih.gov/pubmed/37686557
http://dx.doi.org/10.3390/cancers15174281
work_keys_str_mv AT berzenjilawek minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand
AT wenwen minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand
AT verledenstijn minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand
AT claeserik minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand
AT yogeswaransureshkrishan minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand
AT lauwerspatrick minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand
AT vanschilpaul minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand
AT hendriksjeroenmh minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand